Integrilin eptifibatide: Phase IV data

In the open-label, U.S. Phase IV CLEAR PLATELETS 2 study in 200 patients, Integrilin plus bivalirudin significantly inhibited platelet aggregation compared with bivalirudin alone (p<0.01). The trial e...